Genie Health, a Singapore-based healthtech company, announced on October 21, 2026 that it has raised US$3 million in Seed funding to expand its health intelligence platform for individuals and healthcare providers. The round was led by the Nadathur Family Office, with participation from Liminal, a Founders' Studio backed by Temasek, and two seasoned healthcare leaders. Anand Nadathur, Principal of the Nadathur Family Office, will join the company's board of directors.
A Two-Sided Health Intelligence Platform
The company is building a two-sided platform that helps individuals understand their health and next steps while helping providers strengthen engagement and deliver more personalized care. Its consumer app, Genie, consolidates health reports, lab results, wearable data, connected devices, and family history into a secure health locker. For clinics, Genie SmartCare uses agentic AI to manage patient engagement, appointment bookings, and follow-ups while providing longitudinal insights for care teams.
Funding Plans and Market Context
The new capital will support deeper AI capabilities, faster adoption of Genie SmartCare among clinics, and expanded product, engineering, and healthcare expertise in Singapore. The company points to a growing need for preventive care, with one in three Singapore residents managing at least one chronic condition. At the same time, health information remains scattered across reports, apps, wearables, and providers, creating demand for unified intelligence.
Founding Team Experience
Genie Health was co-founded by Hari V. Krishnan, Maya Hari, and Sandeep Suvarna, who bring experience scaling consumer and enterprise technology businesses. Hari previously served as CEO and Managing Director of PropertyGuru Group, where he led its NYSE listing and sale to EQT for US$1.1 billion. Maya is the former CEO of Terrascope and previously led Twitter's regional business, while Sandeep headed international marketing at Twitch and APAC marketing at LinkedIn.
Investor Perspectives
Anand Nadathur said the firm backs founders who are capable, committed, and aligned with long-term values, and that Genie Health applies deep consumer platform experience to a space where technology can improve health engagement. Philip Chan, Senior Builder at Liminal, noted the team's track record and the compelling opportunity for AI to make better use of fragmented health information. Hari V. Krishnan added that the funding will enable the company to scale both products faster while deepening its platform capabilities.
Product Availability
Genie is available for free on iOS and Android, giving members access to personalized insights and guidance from their own health data. The company emphasizes that members retain control of their health information at all times, while healthcare providers using Genie SmartCare maintain complete oversight of automated patient interactions. The platform is designed to help users understand what their health data means and what to do next, moving beyond generic advice from friends or social media.
With a founding team that has scaled major consumer platforms across Asia and backing from investors focused on long-term impact, Genie Health is positioning itself to address rising demand for preventive and personalized care. The company plans to use the Seed round to deepen its technology and increase adoption among Singapore clinics. As health data becomes more fragmented, Genie Health aims to turn that information into useful intelligence for both patients and providers.